The FDA Just Gave Oncolytics Biotech A Big Bump By: Benzinga via Benzinga February 11, 2015 at 14:36 PM EST The FDA gave Orphan Drug Status to Oncolytics Biotech, Inc. (USA) (NASDAQ: ONCY)'s Ovarian Cancer drug, Reolysin, on ... Read More >>